Industry Trends_NEWS_Beyomed Medical

Two sessions of advice: prudent in high-end medical devices to implement the "4 + 7" procurement with volume

At the annual two sessions of the National Committee of the Chinese People's Political Consultative Conference (CPPCC), Chang Zhaohua, a member of the Standing Committee of the CPPCC National Committee, Vice Chairman of the All-China Federation of Industry and Commerce, and Chairman and CEO of Shanghai Wicresoft Medical Devices (Group) Co., Ltd, said that the pilot "4+7" procurement with volume is one of the exploratory measures of the Health Insurance Bureau to solve the problem of "health insurance gap" in China, which may have a positive effect on reducing drug prices, eliminating some unreasonable intermediate links, and saving limited national health insurance funds; however, this approach has still caused a huge impact in the pharmaceutical industry.

2021-10-21

Looking forward to the early inclusion of the medical insurance law into the legislative planning

Zheng Gongcheng, a delegate to the National People's Congress and president of the Chinese Society of Social Security, suggested that a medical insurance law be enacted as soon as possible to establish a nationwide unified medical insurance system that covers all people. According to Zheng, the goal of the reform of the medical insurance system is not how much money has been deposited in the individual accounts of medical insurance, but to play the role of mutual aid and assistance, so that all people do not become poor due to illness, return to poverty due to illness, and do not affect the quality of life due to illness.

2021-10-21

Two sessions of advice: prudent in high-end medical devices to implement the "4 + 7" procurement with volume

At the annual two sessions of the National Committee of the Chinese People's Political Consultative Conference (CPPCC), Chang Zhaohua, a member of the Standing Committee of the CPPCC National Committee, Vice Chairman of the All-China Federation of Industry and Commerce, and Chairman and CEO of Shanghai Wicresoft Medical Devices (Group) Co., Ltd, said that the pilot "4+7" procurement with volume is one of the exploratory measures of the Health Insurance Bureau to solve the problem of "health insurance gap" in China, which may have a positive effect on reducing drug prices, eliminating some unreasonable intermediate links, and saving limited national health insurance funds; however, this approach has still caused a huge impact in the pharmaceutical industry.

2021-10-21

Two sessions of advice: prudent in high-end medical devices to implement the "4 + 7" procurement with volume

Two sessions of advice: prudent in high-end medical devices to implement the "4 + 7" procurement with volume

Looking forward to the early inclusion of the medical insurance law into the legislative planning

Two sessions of advice: prudent in high-end medical devices to implement the "4 + 7" procurement with volume

Beyomed News

New Product Launch

Industry Trends

Exhibitions